Stevens-Johnson Drug Claims in California: Fight Back

Understanding SJS and TEN After Medication

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare, severe reactions that often begin with flu-like symptoms and can rapidly progress to painful rash, blistering, and skin detachment. Mucous membranes (eyes, mouth, genitals) are commonly involved, and survivors can face long-term complications including vision loss, scarring, and organ issues [1][2]. Certain prescription and over-the-counter medications have been associated with SJS/TEN, but causation is complex and must be medically assessed. Do not stop a prescribed medication without medical advice. If symptoms begin after starting or changing a medication, seek immediate medical care and keep the medication and packaging.

Potential Legal Theories in California

Depending on the facts, California law may allow claims such as: (1) failure to warn (including under the learned intermediary doctrine, where manufacturers must adequately warn prescribers) [4]; (2) negligence; and (3) breach of warranty. Strict liability design-defect claims against prescription drug manufacturers are limited in California under Brown v. Superior Court, which generally precludes strict liability for prescription drug design defects, focusing claims instead on warnings and negligence [3].

Responsibility for warnings can be nuanced. California recognizes that a brand-name manufacturer may, in certain circumstances, owe a duty to patients who ultimately received a generic version with equivalent labeling (innovator liability) under T.H. v. Novartis [5]. By contrast, many failure-to-warn and design-defect claims against generic manufacturers are often preempted by federal law (PLIVA v. Mensing; Mutual Pharmaceutical v. Bartlett) [6][7]. Case viability turns on the specific drug, label history, medical facts, and parties involved.

Who May Be Responsible

Potential defendants may include the brand-name drug manufacturer, in some cases generic manufacturers (subject to significant federal preemption defenses) [6][7], and, depending on the facts, other parties in the chain of distribution. Claims against healthcare providers may arise under medical negligence standards (e.g., prescribing decisions or failure to warn of known risks), which differ from product liability standards. Whether pharmacies or distributors may be liable is fact-specific and subject to defenses and doctrines applicable to prescription products.

Key Evidence to Preserve

Early, thorough documentation is critical:

• Medication bottles, packaging, lot numbers, receipts, and inserts.
• Clear photos of the rash and its progression; wound/burn unit records.
• Hospital and clinic records, lab results, biopsy/pathology reports.
• A timeline of medication starts, stops, and dose changes.
• Communications with prescribers, pharmacies, and insurers.
• Proof of lost wages and out-of-pocket expenses.

Store recalled or remaining pills and packaging in a safe place. Do not alter labels or write on containers.

Medical Causation and Expert Support

SJS/TEN litigation typically requires expert support (dermatology, ophthalmology, pharmacology/pharmacovigilance). Treating notes on timing, dechallenge/rechallenge, and exclusion of alternative causes are often pivotal. Early coordination with specialists and rehabilitation providers helps document severity and long-term impacts [1][2].

Compensation You May Seek

Depending on the case, recoverable damages may include medical expenses (past/future), lost income and diminished earning capacity, pain and suffering, disfigurement and disability, assistive devices, and home modifications. In appropriate cases and with the required proof, punitive damages may be available under California law (Civil Code § 3294) [8]. Families may pursue wrongful death claims when a loved one passes away from SJS/TEN.

Deadlines to File in California

California imposes strict filing deadlines that vary by claim type and facts. Many personal injury/product liability claims have a two-year statute of limitations (Code Civ. Proc. § 335.1) [9]. Medical malpractice claims have different timelines, generally the earlier of three years from the date of injury or one year from discovery, with specific statutory nuances (Code Civ. Proc. § 340.5) [10]. Additional deadlines or administrative requirements may apply depending on the defendant and circumstances. Because time limits can be complex and exceptions may apply, consult an attorney promptly.

What To Do Now

• Get immediate medical care and follow specialist guidance.
• Photograph injuries regularly and keep a symptom journal.
• Preserve all medications, packaging, and receipts.
• Request complete medical records, including imaging and pathology.
• Avoid posting medical details publicly while your case is pending.
• Speak with a California attorney experienced in SJS/TEN and pharmaceutical litigation to evaluate your options.

Ready to talk? Contact our team.

FAQ

What drugs are most commonly associated with SJS/TEN?

Associations have been reported with certain antibiotics, anticonvulsants, NSAIDs, and others. Causation must be evaluated by physicians based on your specific history.

Can I sue if I took a generic drug?

Many claims against generic manufacturers face federal preemption, but California recognizes potential innovator liability against brand manufacturers in some circumstances. Case viability is fact-specific.

How quickly should I contact a lawyer?

Immediately. Statutes of limitations and evidence preservation issues arise early, and deadlines vary by claim and facts.

Will filing a claim affect my ongoing medical care?

Your health comes first. Coordinate with your care team; your attorney can help obtain records and communicate with insurers while you focus on recovery.

How Our Firm Helps

We act quickly to secure medical and pharmacy records, work with leading experts to assess causation and labeling, identify all responsible parties, and pursue compensation through negotiation or litigation. We handle communications with insurers and manufacturers so you can focus on healing. Start your confidential consultation today: /contact.

References

• [1] MedlinePlus, “Stevens-Johnson syndrome” (U.S. National Library of Medicine). https://medlineplus.gov/ency/article/000852.htm
• [2] Genetic and Rare Diseases Information Center (GARD), NIH/NCATS, “Stevens-Johnson syndrome.” https://rarediseases.info.nih.gov/diseases/6092/stevens-johnson-syndrome
• [3] Brown v. Superior Court, 44 Cal.3d 1049 (1988). https://law.justia.com/cases/california/supreme-court/3d/44/1049.html
• [4] Carlin v. Superior Court, 13 Cal.4th 1104 (1996). https://law.justia.com/cases/california/supreme-court/4th/13/1104.html
• [5] T.H. v. Novartis Pharmaceuticals Corp., 4 Cal.5th 145 (2017). https://law.justia.com/cases/california/supreme-court/2017/s233898.html
• [6] PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011). https://supreme.justia.com/cases/federal/us/564/604/
• [7] Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 (2013). https://supreme.justia.com/cases/federal/us/570/472/
• [8] Cal. Civ. Code § 3294 (Punitive damages). https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=CIV&sectionNum=3294
• [9] Cal. Code Civ. Proc. § 335.1 (Two-year limitations period). https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=CCP&sectionNum=335.1
• [10] Cal. Code Civ. Proc. § 340.5 (Medical malpractice limitations). https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=CCP&sectionNum=340.5

Disclaimer

This post is for general informational purposes only and is based on California law as of the date noted. It is not legal or medical advice and does not create an attorney-client relationship. Laws change and outcomes depend on specific facts. If you are outside California, rules and deadlines may differ. For advice about your situation, consult a licensed California attorney. For medical concerns, consult a qualified healthcare professional.